$VRTX
Price history, market instrument context, member research, and related headlines in one place.
VRTX key statistics
NasdaqGSUSD
52-week range
$403.1667%$560.25
Latest session $507.21–$517.68Vertex Pharmaceuticals Incorporated (VRTX) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $508.75, up $10.25 (2.06%) from the previous close of $498.50. It has traded between $507.21 and $517.68 in the latest session. Over the past year it has ranged from $403.16 to $560.25, leaving it in the upper half of its 52-week range (67%). Reported volume for the session was 2.2M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Vertex Resource Group Ltd. GAAP EPS of $0.01, revenue of $51.23M — See source for full details.
Vertex Pharmaceuticals stock hits all-time high at 546.17 USD — See source for full details.
Bernstein Names Top Biotech Stock Pick: Vertex Leads After Rival Drug Fails — See source for full details.
Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough? — See source for full details.
Wolfe Research raises Vertex stock price target on CF franchise value — See source for full details.
Vertex stock surged Monday after its competitor, Sionna, missed the mark for its highly anticipated cystic fibrosis treatment.
Loading $VRTX research…